APA (7th ed.) Citation

Nedosugova, L. V., Petunina, N. A., & Galstyan, K. O. Initial investigation of efficacy and safety of a new dipeptidyl peptidase-4 inhibitor, gosogliptin, for type 2 diabetes in Russia. Endocrinology Research Centre.

Chicago Style (17th ed.) Citation

Nedosugova, Lyudmila Viktorovna, Nina Alexandrovna Petunina, and Karina Oganesovna Galstyan. Initial Investigation of Efficacy and Safety of a New Dipeptidyl Peptidase-4 Inhibitor, Gosogliptin, for Type 2 Diabetes in Russia. Endocrinology Research Centre.

MLA (9th ed.) Citation

Nedosugova, Lyudmila Viktorovna, et al. Initial Investigation of Efficacy and Safety of a New Dipeptidyl Peptidase-4 Inhibitor, Gosogliptin, for Type 2 Diabetes in Russia. Endocrinology Research Centre.